NEW YORK (GenomeWeb News) – Celera today released preliminary revenue results for the second quarter of 2009, which it expects to be down between 2 percent and 7 percent from its Q2 2008 revenues. In light of these results, the company announced that it is immediately implementing a restructuring program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.